Use of rituximab in combination with high-dose methotrexate in the treatment of primary central nervous system lymphoma in a mycophenolate mofetil treated patient with lupus nephritis

MeSH terms

• Antibodies, Monoclonal, Murine-Derived / administration & dosage
• Antibodies, Monoclonal, Murine-Derived / adverse effects
• Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
• Antineoplastic Combined Chemotherapy Protocols / adverse effects*
• Bacteremia / immunology
• Bacteremia / microbiology
• Central Nervous System Neoplasms / complications
• Central Nervous System Neoplasms / drug therapy*
• Drug Administration Schedule
• Female
• Fever / microbiology
• Fungemia / immunology
• Fungemia / microbiology
• Humans
• Immunocompromised Host*
• Immunosuppressive Agents / administration & dosage
• Immunosuppressive Agents / adverse effects*
• Lupus Nephritis / complications
• Lupus Nephritis / drug therapy*
• Lymphoma / complications
• Lymphoma / drug therapy*
• Methotrexate / administration & dosage
• Methotrexate / adverse effects
• Mycophenolic Acid / administration & dosage
• Mycophenolic Acid / adverse effects
• Mycophenolic Acid / analogs & derivatives*
• Neurotoxicity Syndromes / etiology
• Neutropenia / chemically induced
• Neutropenia / complications
• Rituximab
• Treatment Outcome
• Young Adult